The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The latest information on record including appeal was placed and considered.
Reg. Raise in admission in B.Pharm course from 60-100 Seats
It was decided to permit raise in admission from 60 to 100 seats from 2023-2024 academic session for B.Pharm. Course.

(Permitted raise in admissions from 60
to 100 from 2020-2021 academic session )

Extend approval upto 2023-2024 academic session for 100 admissions for B.Pharm course.

Decision: 05-days’ time to be given to institute to submit the compliance with Affidavit and if fails to submit then treated as rejected for session 2023-24 and no further chance will be given to institute.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

Decision: 05-days’ time to be given to institute to submit the compliance with Affidavit and if fails to submit then treated as rejected for session 2023-24 and no further chance will be given to institute.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

(100 intake is approved in 2019-2020 a.s.)

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for increase intake B.Pharm and M.Pharm. courses session 2023-24.

Grant approval for 2023-2024 academic session for the conduct of 1st year
M. Pharm: Pharmacology – 15 Seats
B.Pharm: from 60 to 100 seats

The Pharmacy Council of India in its decision on 30.11.2023 has considered all pending applications with or without deficiency in terms of order dated 29.11.2023 of Hon’ble Delhi High Court in Cont. Cas 1705 of 2023 and other connected matters whereby the Hon’ble Court had directed the Pharmacy Council of India to grant the approval to all institutions whose applications are pending for approval, though their deficiencies were communicated or not, subject to such institutions submitting an affidavit in 2 days with an undertaking to remove their respective deficiencies, if any, within a period of 7 days thereafter.

The Pharmacy Council of India, therefore, on 30.11.023 has decided as under-
The institution is granted permission for the Academic Year 2023-24, however subject to the Principal of the Institution submitting an undertaking on an affidavit within 2 days to the effect that the deficiencies pointed out in the inspection stands rectified within a period of 7 days thereafter.

1. The consent of affiliation for raise in intake is not available for 2023-24 academic session.
2. Museum , Balance Room , store Rooms not shown.
3.. Licensed plagiarism software – not available
4. Audited financial statement – not available
5. Fuming cub board, gas fitting, exhaust fans not available.
6. CCTV not available.
7. Biometric attendance system for faculty and students – not available
8. All equipment are not properly”

B.Pharm
Grant approval for Raise in Intake in B. Pharm course from 60 to 100 seats for 2023-2024 academic session.

B.Pharm
Extend approval upto 2023-2024 academic session for 38 admissions for B. Pharm course.

Regarding raise in admission in B. Pharm course –
It was noted that institution has failed to submit consent of affiliation of examining authority for raise in admission for B. Pharm course.

In view above, It was decided to instruct the institution to submit the above compliance within 7 days through dashboard.

Granted approval from 2019-2020 to 2023-2024 academic session for 60 admissions u/s 12 for B.Pharm course

Grant approval from 2019-2020 to 2023-2024 academic session for 100 admissions u/s 12 of the Pharmacy Act for B.Pharm Course.

(Raise in admission from 60 to 100 was granted from 2020-2021 academic session)

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.
In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B. Pharm
Extend approval upto 2023-2024 academic session for 60 admissions for B.Pharm course.

B.Pharm
Grant approval for 2023-2024 academic session for the conduct of 4th year for B.Pharm course.
Allow 100 admissions in 2023-2024 academic session in 1st year.

Read (Revised Decision)

B.Pharm
Grant approval from 2019-2020 to 2023-2024 academic session for 100 admissions u/s 12 of the Pharmacy Act for B.Pharm course.

B.Pharm
Extend approval upto 2023-2024 academic session for 38 admissions for B. Pharm course.

It is again informed as under-
Regarding raise in admission in B. Pharm course –
It was noted that institution has failed to submit consent of affiliation of examining authority for raise in admission for B. Pharm course.

In view of above, your application for raise in admission B. Pharm course for 2023-2024 academic session is rejected.

The institution is granted permission for the Academic Year 2023-24, however subject to the Principal of the Institution submitting an undertaking on an affidavit within 2 days to the effect that the deficiencies pointed out in the inspection stands rectified within a period of 7 days thereafter. If any deficiency found subsequently on inspection, the institution will not be considered for approval for 2024-2025 academic session.

Building Plan not attached. Labs & Library needs upgradation. More Books & Equipments required Model Pharmacy not shown. Salary Proof of Staff not given with Bank detail. Teacher cadre Ratio to be maintained.

B.Pharm
B.Pharm course is already approved upto 2023-2024 academic session for 60 admissions.

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for Raise in admission in B.Pharm. from 60.-100 Seats
Permit Raise in admission in B.Pharm: 60 to 100 Seats.

Regarding Raise in admission in B.Pharm course, 398 EC (27.7.2023 & 28.7.2023) decided as under –

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise intake: B.Pharm from 60 to 100 seats
1. NOC not received yet.
2. Occupancy certificate not available
3. Structure Stability certificate issued by Competent authority not available.
4. Principal not eligible as per norms.
5. Licensed plagiarism software – not available.
6. Biometric attendance system for students – not available
7. Biometric attendance system for Faculty – not available
8. General Insurance not available.
9. Smart classroom not available
10. Triple door entering setup for aseptic room not available.
11. Gas Connection Proof and receipt not available.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

Regarding Raise in admission in B.Pharm course, 399 EC (11.8.2023) decided as under –

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise intake: B.Pharm from 60 to 100 seats
1. NOC not received yet.
2. Occupancy certificate not available
3. Structure Stability certificate issued by Competent authority not available.
4. Principal not eligible as per norms.
5. Licensed plagiarism software – not available.
6. Biometric attendance system for students – not available
7. Biometric attendance system for Faculty – not available
8. General Insurance not available.
9. Smart classroom not available
10. Triple door entering setup for aseptic room not available.
11. Gas Connection Proof and receipt not available.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

B.Pharm
Extend approval upto 2023-2024 academic session for 60 admissions for B.Pharm course.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

396 EC (1.6.2023) decided as under –
The latest information on record including appeal was placed and considered.

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise in Intake & Introduction of New course/course:

The following deficiencies was pointed out in inspection reports:

1. Consent of Affiliation of the Examining Authority for M.Pharm for 2023-24 academic session – Not available.
2. Some GST paid bills for furniture chemicals glassware and equipments was unable to shown
3. Some bills were unable to show.
4. No of Labs and classroom not mentioned
5. Faculty cadre ratio not maintained

In view of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-24 and no further chance will be given to institute.

398th EC decision decided as under:-

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for
Increase intake B.Pharm course from 60 to 100 session 2023-24.

Raise in admission in B.Pharm from 60 to 100 seats granted

Extend approval upto 2025-2026 academic
session for 60 admissions

The Pharmacy Council of India in its decision on
30.11.2023 has considered all pending applications
with or without deficiency in terms of order dated
29.11.2023 of Hon’ble Delhi High Court in Cont. Case
1705 of 2023 and other connected matters whereby
the Hon’ble Court had directed the Pharmacy Council
of India to grant the approval to all institutions whose
applications are pending for approval, though their
deficiencies were communicated or not, subject to
such institutions submitting an affidavit in 2 days with
an undertaking to remove their respective
deficiencies, if any, within a period of 7 days thereafter.

The Pharmacy Council of India, therefore, on
30.11.2023 has decided as under The institution is granted permission for the Academic Year 2023-24, however subject to the Principal of the Institution submitting an undertaking on an affidavit within 2 days to the effect that the deficiencies pointed out in the inspection stands rectified within a period of 7 days thereafter.

1. Consent of affiliation of D. Pharm. of university was of A Y 2022-23
2. Original copy of PAN was not shown. Only copy in mobile phone was shown.
3. GST Registration certi. – Original copy was not shown. Only copy in mobile phone was shown
4. Construction cost of Building not provided.
5. Engineering course was run on building previously.
6. CA certification on bills were missing
7. Separate Social Pharmacy lab is not available. Pharmacy Space of Practice lab is utilized for social pharmacy lab.
8. GSTR 3B not available.

B.Pharm
Extension of approval for 2023-2024 academic session for B.Pharm course.

(Permit raise in admissions from 60 to 100 from 2023-2024 a.s.)

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

Decision of 403 EC (01.12.2023) is as under-

– Council received mail dt.10.10.2023 form institution therewith requesting for change of Examining Authority from Andhra University (Andhra Pradesh) to Jawaharlal Nehru Technological University, Kakinada (Andhra Pradesh) from the academic year 2015- 2016 in respect of Emmanual College of Pharmacy, Vishakhapatnam (Andhra Pradesh). In this regard institution has submitted following documents –

a) NOC of Andhra University from 2015-2016.
b) Consent of affiliation of JNTU, Kakinada from 2015-2016.

– It was decided to approve the change of examining authority as per the following details –

From
The Registrar,
Andhra University
Visakhapatnam (Andhra Pradesh).

Upto 2014-15 academic session

To
The Registrar
Jawaharlal Nehru Technological University
Kakinada, Hyderabad (Andhra Pradesh).

w.e.f. 2015-16 academic session onwardsDecision of 403 EC (01.12.2023) is as under-

– Council received mail dt.10.10.2023 form institution therewith requesting for change of Examining Authority from Andhra University (Andhra Pradesh) to Jawaharlal Nehru Technological University, Kakinada (Andhra Pradesh) from the academic year 2015- 2016 in respect of Emmanual College of Pharmacy, Vishakhapatnam (Andhra Pradesh). In this regard institution has submitted following documents –

a) NOC of Andhra University from 2015-2016.
b) Consent of affiliation of JNTU, Kakinada from 2015-2016.

– It was decided to approve the change of examining authority as per the following details –

From
The Registrar,
Andhra University
Visakhapatnam (Andhra Pradesh).

Upto 2014-15 academic session

To
The Registrar
Jawaharlal Nehru Technological University
Kakinada, Hyderabad (Andhra Pradesh).

w.e.f. 2015-16 academic session onwards

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for increase intake in B.Pharm course session 2023-24.
Raise in admission in B.Pharm from 60 to 100 seats granted

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for increase intake in B.Pharm course session 2023-24.

Raise in admission in B.Pharm from 30 to 60 seats granted

The Pharmacy Council of India in its decision on
30.11.2023 has considered all pending applications
with or without deficiency in terms of order dated
29.11.2023 of Hon’ble Delhi High Court in Cont. Case
1705 of 2023 and other connected matters whereby
the Hon’ble Court had directed the Pharmacy Council
of India to grant the approval to all institutions whose
applications are pending for approval, though their
deficiencies were communicated or not, subject to
such institutions submitting an affidavit in 2 days with
an undertaking to remove their respective
deficiencies, if any, within a period of 7 days thereafter.

The Pharmacy Council of India, therefore, on
30.11.2023 has decided as under The institution is granted permission for the Academic
Year 2023-24, however subject to the Principal of the
Institution submitting an undertaking on an affidavit
within 2 days to the effect that the deficiencies
pointed out in the inspection stands rectified within a
period of 7 days thereafter.

1. State NOC not available.
2. Library Management Software for Entry/Issue/Returns Books not available.
3. Licensed Plagiarism Software not available.
4. Pay scale, Teaching/ Non-teaching not as per UGC/ AICTE / STATE GOVERNMENT.
5. Biometric attendance system for faculty and students not available.
6. Latest I.P. not available.

B.Pharm

Extension of approval for 2023-2024 academic session for B.Pharm course.
(Permit raise in admissions from 60 to 100 from 2023-2024 a.s.)

Grant approval for 2023-2024 academic session for and also permit to Raise in Admissions in B.Pharm from 60 to 100 Seats.

Decision of 30.11.2023 is as under
Regarding raise in admission for B.Pharm course –

It is again informed as under-
It was noted that despite giving reasonable time for submission of Statutory documents, your institution has failed to submit following statuary documents for raise in admission for B.Pharm course for 2023-2024 academic session-
• consent of affiliation of examining authority for raise in admission for B. Pharm course.

In view of above, your application for 2023-2024 academic session is hereby rejected.

Regarding raise in admission in B.Pharm, It is again informed as under-
1) It was noted that despite giving reasonable time for submission of Statutory documents, your institution has failed to submit consent of affiliation of examining authority for raise in admission for B.Pharm course from 2023-2024 academic session.
2) In view of above, your application for raise in admission for B.Pharm course for 2023-2024 academic session is hereby rejected.

396 EC (1.6.2023) decided as under-
Reg. Raise in admissionin B.Pharm course

It was decided to permit raise in admission from 60 to 100 from 2023-2024 academic session

The Pharmacy Council of India in its decision on
30.11.2023 has considered all pending applications
with or without deficiency in terms of order dated
29.11.2023 of Hon’ble Delhi High Court in Cont. Case
1705 of 2023 and other connected matters whereby
the Hon’ble Court had directed the Pharmacy Council
of India to grant the approval to all institutions whose
applications are pending for approval, though their
deficiencies were communicated or not, subject to
such institutions submitting an affidavit in 2 days with
an undertaking to remove their respective
deficiencies, if any, within a period of 7 days thereafter.

The Pharmacy Council of India, therefore, on
30.11.2023 has decided as under The institution is granted permission for the Academic
Year 2023-24, however subject to the Principal of the
Institution submitting an undertaking on an affidavit
within 2 days to the effect that the deficiencies
pointed out in the inspection stands rectified within a
period of 7 days thereafter.

1. State NOC not available.
2. Library Management Software for Entry/Issue/Returns Books not available.
3. Licensed Plagiarism Software not available.
4. Pay scale, Teaching/ Non-teaching not as per UGC/ AICTE / STATE GOVERNMENT.
5. Biometric attendance system for faculty and students not available.
6. Latest I.P. not available.

B.Pharm

Extension of approval for 2023-2024 academic session for B.Pharm course.
(Permit raise in admissions from 60 to 100 from 2023-2024 a.s.)

Grant for B Pharm Course Raise in admission from 60-100 intake

The Pharmacy Council of India in its decision on
30.11.2023 has considered all pending applications
with or without deficiency in terms of order dated
29.11.2023 of Hon’ble Delhi High Court in Cont. Case
1705 of 2023 and other connected matters whereby
the Hon’ble Court had directed the Pharmacy Council
of India to grant the approval to all institutions whose
applications are pending for approval, though their
deficiencies were communicated or not, subject to
such institutions submitting an affidavit in 2 days with
an undertaking to remove their respective
deficiencies, if any, within a period of 7 days thereafter.

The Pharmacy Council of India, therefore, on
30.11.2023 has decided as under The institution is granted permission for the Academic
Year 2023-24, however subject to the Principal of the
Institution submitting an undertaking on an affidavit
within 2 days to the effect that the deficiencies
pointed out in the inspection stands rectified within a
period of 7 days thereafter.

1. GST Registration Certificate not available.
2. Building insurance certificate is not Available
3. MARATHA MANDAL POLYTECHNIC is running in the same Building.
4. Bills not CA Certified

B.Pharm

Extension of approval for 2023-2024 academic session for B.Pharm course.
(Permit raise in admissions from 60 to 100 from 2023-2024 a.s.)

Regarding raise in admission in B.Pharm course,398 EC (27.7.2023 & 28.7.2023) decided as under –

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for B.Pharm. (Raise intake)

1. CLU issued by competent authority not available
2. Occupancy certificate not available
3. Latitude & longitude of the institute – not showed relate to document.
4. Principal not eligible.
5. Class room size is small for 100 intake.
6. Seminar Hall has very low capacity.
7. Generator Room/Facility not available.
8. Ramp not available.
9. Faculty Insufficient.
10. Journal subscription & periodical register not available.
11. library management software for entry – not available.
12. Internet facility not available.
13. Latest Indian pharmacopoeia- not available
14. Licensed plagiarism software – not available
15. Titles not given.
16. Pay scale not provided.
17. Some Bills not available.
18. Proof of provision of internet bandwidth not available.
19. Fuming cub board, gas fitting, exhaust fans not available.
20. CCTV not available.
21. Biometric attendance system for students – not available
22. Biometric attendance system for Faculty – not available
23. General Insurance not available.
24. Smart classroom not available
25. Pharmacology software not available.
26. Triple door entering setup for aseptic room not available.
27. Model pharmacy laboratory has no provision of drug information centre and patient counselling centre.
28. All equipment are not properly displayed with sop in laboratories, 35) Display of chart in respective laboratories not available.
29. Electricity details not available.
30. Instrument numbering register not available.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for increase intake in B.Pharm course session 2023-24.

Raise in admission in B.Pharm from 60 to 100 seats granted

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The institution is granted permission for the Academic Year 2023-24, however subject to the Principal of the Institution submitting an undertaking on an affidavit within 2 days to the effect that the deficiencies pointed out in the inspection stands rectified within a period of 7 days thereafter. If any deficiency found subsequently on inspection, the institution will not be considered for approval for 2024-2025 academic session.

No model pharmacy Labs & Library needs upgradation. More Books & Equipments required Teacher cadre Ratio to be maintained. Salary Proof of Staff not given with Bank detail.

B.Pharm
Extend approval upto 2023-2024 academic session for 60 admissions for B.Pharm course.

Minute of 397EC decided as under:

Regarding raise in admission in B.Pharm course –
Thelatestinformationonrecordincludingappeal wasplaced andconsidered.

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise in intake: (B.Pharm)

The following deficiencies was pointed out in inspection reports:

1. Consent of affiliation for B. Pharm not shown.
2. GST Registration Certificate not available.
3. Bank account details not shown.
4. Faculty consent not shown.
5. Faculty resume/CV not available
6. Building Completion Certificate not available.
7. GSTR 3B not available.
In view of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-24 and no further chance will be given to institute.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B.Pharm
Extend approval upto 2023-2024 academic session for 100 admissions for B.Pharm course.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

Regarding raise in admission in B.Pharm Course
It is again informed as under-
1) It was noted that despite giving reasonable time for submission of Statutory documents, your institution has failed to submit consent of affiliation of examining authority for raise in admission for B.Pharm course from 2023-2024 academic session.
2) In view of above, your application for raise in admission for B.Pharm course for 2023-2024 academic session is hereby rejected.

The institution is granted permission for the Academic Year 2023-24, however subject to the Principal of the Institution submitting an undertaking on an affidavit within 2 days to the effect that the deficiencies pointed out in the inspection stands rectified within a period of 7 days thereafter. If any deficiency found subsequently on inspection, the institution will not be considered for approval for 2024-2025 academic session.
Salary Proof of Staff not given with Bank detail. Approved Building Plan not shown. Ramp not shown. Equipments & Chemicals less. Labs and Library need to Improve. No museum shown. Boys and Girls common Room not shown. Model Pharmacy not shown.

B.Pharm
Grant approval from 2019-2020 to 2023-2024 academic session for 60 admissions u/s 12 of the Pharmacy Act for B.Pharm course.

Grant approval from 2022-2023 to 2023-2024 academic session for 100 admissions u/s 12 of the Pharmacy Act for B.Pharm course.

(Permit raise in admission from 60 to 100 from 2022-2023 a.s. for B.Pharm course)

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

Grant approval from 2022-2023 to 2023-2024 academic session for 100 admissions u/s 12 of the Pharmacy Act for B.Pharm course.

(Permit raise in admissions from 60 to 100 from 2022-2023 academic session)

Regarding raise in admission in B.Pharm, It is again informed as under-
1) It was noted that despite giving reasonable time for submission of Statutory documents, your institution has failed to submit consent of affiliation of examining authority for raise in admission for B.Pharm course from 2023-2024 academic session.
2) In view of above, your application for raise in admission for B.Pharm course for 2023-2024 academic session is hereby rejected.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B.Pharm
Grant approval for 2023-2024 academic session for raise in admission from 60 to 100 seat.

Regarding Raise in admission in B.Pharm course, 399 EC ( 11.8.2023) decided as under –
The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for M.Pharm Pharmaceutics course. & Raise in intake B.Pharm 60 to 100.
The following deficiencies was pointed out in inspection reports :
1. NOC for increase in intake & New M.Pharm course is not available.
2. No. of Staff is not adequate.
3. No Professor in Pharmaceutics available.
4. No. of Labs is less
5. No class room for M.Pharm.
6.Library management software not available.
7. No Photocopier.
8. No latest I.P. available..
9. Licensed Plagiarism not available.
10. Biometric system for students not available.
11. General Insurance not available.
12. Triple door entering setup for aseptic room not available.
13. Model pharmacy laboratory has no provision of drug information centre and patient counselling centre.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The Pharmacy Council of India in its decision on 30.11.2023 has considered all pending applications with or without deficiency in terms of order dated 29.11.2023 of Hon’ble Delhi High Court in Cont. Cas 1705 of 2023 and other connected matters whereby the Hon’ble Court had directed the Pharmacy Council of India to grant the approval to all institutions whose applications are pending for approval, though their deficiencies were communicated or not, subject to such institutions submitting an affidavit in 2 days with an undertaking to remove their respective deficiencies, if any, within a period of 7 days thereafter.

The Pharmacy Council of India, therefore, on 30.11.023 has decided as under-
The institution is granted
permission for the Academic Year 2023-24, however
subject to the Principal of the Institution submitting an
undertaking on an affidavit within 2 days to the effect
that the deficiencies pointed out in the inspection
stands rectified within a period of 7 days thereafter.

following deficiency
Salary given not as per norms.
Fuming Hood in Pharma chemistry Lab. was not arrenged properly.
GSTR 3B not available.
Bank deatils of salary of faculty not showing.
Medicinal chemistry lab was not shown properly.

B.Pharm
Grant approval for 2023-2024 academic session for
Application for Raise in intake for B.Pharm 60 to 100 seats course

Regarding change in name of Examining Authority –
It was decided to approve the change in name of Examining Authority as per following details –

From
The Controller of Examination UttarakhandTechnicalUniversity Govt Girls Polytechnic Premnagar Sudhowala Dehradun

To
The Controller of Examination Dev Bhoomi Uttarkhand University Dehradun Uttarakhand

401 EC (3.10.2023) decided to approve the change in the name of Examining Authority as per following details-

From -The Registrar Godwana University MIDC Road Complex Gadchiroli
Upto 2022-2023 academic session

TO – Dr.Babasaheb Ambedkar Technological University, Lonere, Maharashtra
W.e.f 2023-2024 academic session

Regarding raise in admission in B.Pharm course, 399 EC (11.8.2023) decided as under –

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise intake: B.Pharm from 60 to 100 seats
1.library management software for entry – not given
2. Licensed plagiarism software – not available
3. Pharmacology software not available.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

Regarding correction in the name of institution –
It was decided to approve the correction in the name of institution instead of as per following details-
From To
SRI SHATAVAHANA EDUCATIONAL SOCIETY. Teja College Of Pharmacy
Regarding change in the name of college trust/society –
It was decided to approve the change in the name of college trust/society as per following details-
From To

PRABHU TEJA EDUCATIONAL SOCIETY

SRI SHATAVAHANA EDUCATIONAL SOCIETY.
w.e.f. (2023-2024)

Already permitted raise in admission from 60 to 100 from 2021-2022 academic session

Regarding raise in admission in B.Pharm course, 398 EC (27.7.2023 & 28.7.2023) decided as under –

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise intake: B.Pharm from 60 to 100 seats
1.library management software for entry – not given
2. Licensed plagiarism software – not available
3. Pharmacology software not available.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

Thelatestinformationonrecordincludingappeal wasplaced andconsidered.

Reg.Raisein admissioninB.Pharmcourse

It was decided topermitraise inadmission from 60to100 from2023-2024 academic session

Application for B Pharm course is rejected for session 2023-24 due to following deficiency
Salary given not as per norms.
Fuming Hood in Pharma chemistry Lab. was not arrenged properly.
GSTR 3B not available.
Bank deatils of salary of faculty not showing.
Medicinal chemistry lab was not shown properly.”

Regarding raise in admission, 398 EC (27.7.2023 & 28.7.2023) decided as under –
The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for increase intake in B.Pharm course session 2023-24. Raise in admission in B.Pharm from 60 to 100 seats granted

(permit raise in admission 60 to 100 from 2022-2023 academic session for B.Pharm course)

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.
In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

Regarding raise in admission in B.Pharm course , 399 EC (11.8.2023) decided as under –
The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise intake: B.Pharm from 60 to 100 seats
The Following deficiencies were pointed out:
1. Resolution made by Trust / Society not available.
2. Website of the Trust/ society not available.
3. Specialization wise list of books, student visitor book – not available
4. Licensed plagiarism software – not available.
5. Salary acquaintance Register of staff not available.
6. Biometric attendance system for students – not available
7. Triple door entering setup for aseptic room not available.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

Regarding raise in admission in B.Pharm course –

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for Raise in admission in B.Pharm. from 60.-100 Seats
Permit Raise in admission in B.Pharm: 60 to 100 Seats.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

Regarding raise in admission in B.Pharm course , 398 EC (27.7.2023 & 28.7.2023) decided as under –
The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise intake: B.Pharm from 60 to 100 seats
The Following deficiencies were pointed out:
1. Resolution made by Trust / Society not available.
2. Website of the Trust/ society not available.
3. Specialization wise list of books, student visitor book – not available
4. Licensed plagiarism software – not available.
5. Salary acquaintance Register of staff not available.
6. Biometric attendance system for students – not available
7. Triple door entering setup for aseptic room not available.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

(Minutes of 397EC )
Thelatestinformationonrecordincludingappeal wasplaced andconsidered.
The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Raise in Intake(B.Pharm)

The following deficiencies was pointed out in inspection reports:

Note:No. of Seats for Raise in admission in B.Pharm not mentioned by Inspectors.&
No. of Seats for new course in M.Pharm (Pharmaceutics & Pharmacology) not mentioned by Inspectors.

1. GST Registration Certificate not available.
2. NOC and Last Salary certificate not shown by faculty.
3. Certificate of single piece of land not available.
4. Building Insurance certificate is not latest.
5. Building Fire Safety certificate not available.
6. Construction Cost of Building Certificate not shown.
7. Declaration regarding other courses running in same campus not shown.
8. Approved building plan/map not show.
9. Registration of municipality/Tehsil/Panchayat office not provided.
10. Toilets for PH candidates not available.
11.No CA certified GST bills available for equipments, glassware and instruments
12. No CA certified GST bills available for library.
13. No CA certified GST bills available for computer.
14. GSTR 3B not available.
15. Social pharmacy lab not available.
16. Latest electricity bills and telephone bills are on the name of society.
In view of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-24 and no further chance will be given to institute.

6.1 The latest information on record was placed and considered.

6.2 It was noted that –

a) the Council received complaints against institution.

b) 401 EC (3.10.2023) under Item No.29 decided to arrange surprise inspection by deputing observer and inspectors and authorize the Hon’ble President to give the name of one observer and two inspectors for the surprise inspection.

c) Accordingly surprise inspection was arranged to verify the complaints.

6.3 The Inspection report dt.20.11.2023 to 22.11.2023 was placed and considered which reveals that there is no substance in the complaint against the institutions. Hence, no further action is required.

6.4 In view of above, it was decided to –

i) withdraw the show cause notice from Council’s website regarding not to make admissions from 2023-2024 academic session

ii) reiterate the earlier following approval decision and upload on Council website-

B.Pharm
Grant approval from 2019-2020 to 2023-2024 academic session for 60 admissions u/s 12 of the Pharmacy Act for B.Pharm Course.

B.Pharm course is already approved upto 2023-2024 academic session for 60
admissions.

B.Pharm course is already approved upto 2023-2024 academic session for 100 admissions.
Grant for B Pharm Course Raise in admission from 60-100 intake

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection processof 2023-2024 academic session.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.
In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

Regarding raise in admission in B.Pharm course, 398 EC (27.7.2023 & 28.7.2023) decided as under –

The matter pertaining to the grant of approval for the Academic Session 2023-2024 was placed before Executive Committee and considered for Introduction
M.Pharm Pharmacognosy, M.Pharm Pharmaceutical Chemistry and B.Pharm- RAISE intake.
1. NOC of the State Govt. not available.
2. Structure stability certificate not available
3. Latitude & longitude of the institute – not showed relate to document.
4. Faculty Carde Ratio not maintained.
5. Faculty insufficient.
6. One Pharmacognosy Lab. not available.
7. Infrastructure for M.Pharm is not proper.
8. Platform and Floor not proper.
9. Basic Instrument facility is not available.
10. UV not available.
11. Specialization wise list of books, student visitor book – not available
12. Issue/ Return Register not available.
13. library management software for entry – not given
14. Latest Indian pharmacopoeia- not available
15. Licensed plagiarism software – not available
16. Details of salary disbursement bank transfer details – not available
17. Pay scale not provided.
18. Salary acquaintance Register of staff not available.
19. Biometric attendance system for students – not available
20. Biometric attendance system for Faculty – not available
21. Smart classroom not available
22. Triple door entering setup for aseptic room not available.
23. Model pharmacy laboratory has no provision of drug information centre and patient counselling centre.
Decision: In View of above, it was decided that 5 days time to be given to institute to submit the compliance and if fails to submit then treated as rejected for session 2023-2024 and No further chance will be given to institute.

B.Pharm course is already approved upto 2023-2024 academic session for 60
admissions.

Regarding request in “Services” for Change of Examining Authority of institution
It was noted that instituion has failed to submit following statutory documents
NOC of the old Examining Authority is not submitted.”

B.Pharm course is already approved upto 2023-2024 academic session for 100 admissions.

Extend approval upto 2023-2024 academic
session for 100 admissions for B.Pharm
course.

B.Pharm course is already
approved upto 2023-2024
academic session for 100
admissions.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B.Pharm course is already
approved upto 2023-2024
academic session for 100
admissions.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B.Pharm course is already approved
upto 2023-2024 academic session for 60
admissions

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B.Pharm course is already approved upto 2023-2024 academic session for 100 admissions.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B.Pharm

Extend approval upto 2023-2024 academic session for 60 admissions for B.Pharm course.

(Raise in admissions from 60 to 100 from 2020-2021 academic session is already approved)

B.Pharm course is already approved upto 2023-2024 academic session for 100 admissions.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

The last approval for 2022-23 academic session is restored and vide notification dt. 22.10.2022 read with 3.11.2022 instructed the institutions to submit affidavit.

In view of above, it was decided to verify the said affidavit during the inspection process of 2023-2024 academic session.

B.Pharm
Extend approval upto 2023-2024 academic session for 100 admissions for B.Pharm course.

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for increase intake from 60 to 100 seatsin B.Pharm course session 2023-24.
Raise in admission in B.Pharm from 60 to 100 seats granted

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for Raise in admission in B.Pharm. from 60.-100 Seats

Grant approval for 2023-2024 academic session for Raise in admission in B.Pharm: 60 to 100 Seats.

398th EC decision decided as under:-

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for increase intake from 60 to 100 seats in B.Pharm course

Raise in admission in B.Pharm from 60 to 100 seats granted

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for Raise in admission in B.Pharm. from 60.-100 Seats

Grant approval for 2023-2024 academic session for Raise in admission in B.Pharm: 60 to 100 Seats.

B.Pharm
Extend approval up to 2023-2024 academic session for 100 admissions for B. Pharm course.

Subject to verification within one month.

B.Pharm
Extend approval upto 2023-2024 academic session for 60 admissions for B.Pharm course.

B.Pharm
Extend approval upto 2023-2024 academic session for 60 admissions for B.Pharm course.

397 EC decided as under

The matter was discussed at length and after the due deliberation and considering, the latest information/report on record and considered for Raise in Intake for B.Pharm course 60 to 100 seats & New Courses Pharm. D & – Pharm D(PB)- for session 2023-24.
The following deficiencies was pointed out in inspection reports:
1. State NOC for 60 Seats.
2. List of 32 teachers was provided out of which 12 were not present.
3. Staff cadre ratio not maintained.
4. 07 more labs needed for these courses. (Pharm. D &PharmD(PB)-
5. 03 labs are less for M.Pharm. courses
6. Journals not available
7. Latest I.P. not available.
8. Pay scale, Teaching / Non-teaching not as per UGC/ AICTE / STATE GOVERNMENT.
10. Fuming cupboard not available.
11. Biometric attendance system for students not available.
12. Triple door entering setup for aseptic room not available.

Decision: 05-days’ time to be given to institute to submit the compliance with Affidavit and if fails to submit then treated as rejected for session 2023-24 and no further chance will be given to institute.

B.Pharm
Extend approval upto 2023-2024 academic session for 100 admissions for B.Pharm course.